This discovery that newly synthesized DNA remains accessible for hours after replication opens up fascinating possibilities. Targeting this ‘hyperaccessible’ state could allow for more precise cancer treatments that selectively attack rapidly dividing cells.

It also raises questions about whether other diseases could be treated using this technology.

What challenges do you foresee in developing this into a practical therapy?